drugset / Trial / NCT01502631

Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects With Acute Spinal Cord Injury (ASCI)

NCT01502631 ↗

Phase 2 Completed 65 enrolled Daiichi Sankyo
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this research study is to gather scientific information about the effectiveness of the study drug, SUN13837 Injection, when compared with the placebo (inactive substance) in participants with acute spinal cord injury.

Timeline

Start
2012-08-08
Primary completion
2014-09-21
Completion
2014-09-21

Drugs

EvaluationDrugModalityDoseRoute
Comparator SUN13837 Unknown — —

Indications